SP

Sivakaminatha Pillai Senthilnathan

Active Director Director DIN 03500590
DIN 03500590 First appointment Mar 1998 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 1998
Shareholding value β€’β€’β€’β€’ Premium profile

About Sivakaminatha Pillai Senthilnathan

Data last updated:

Sivakaminatha Pillai Senthilnathan is a Director at Sahasra Pharmaceuticals India Private Limited (since 1998). The company operates in Chemicals.

DIN 03500590
Primary Designation Director
Industry Chemicals
First Appointment 27 Mar 1998
Oldest Company Age 28 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Mar 19981998Active

Board colleagues of Sivakaminatha Pillai Senthilnathan

Directorship timeline

Open interactive timeline →
Sahasra Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Sivakaminatha Pillai Senthilnathan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivakaminatha Pillai Senthilnathan

Sivakaminatha Pillai Senthilnathan currently holds 1 directorship: Sahasra Pharmaceuticals India Private Limited (Director, since 27 Mar 1998).

Sivakaminatha Pillai Senthilnathan was first appointed on 27 Mar 1998 as Director at Sahasra Pharmaceuticals India Private Limited.

The current boards of Sivakaminatha Pillai Senthilnathan's companies include Sivakaminatha Pillai Samia (Sahasra Pharmaceuticals India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available